Perils of comparing toxicities between stereotactic body radiation and intensity-modulated radiation therapy for prostate cancer on the basis of incomplete demographic registries

J Clin Oncol. 2014 Oct 20;32(30):3453. doi: 10.1200/JCO.2014.56.4229. Epub 2014 Sep 2.

Authors

Christopher R King¹, Michael S Steinberg², Pat Kupelian²

Affiliations

¹ David Geffen School of Medicine at UCLA, Los Angeles, CA crking@mednet.ucla.edu.
² David Geffen School of Medicine at UCLA, Los Angeles, CA.

PMID: 25185084
DOI: 10.1200/JCO.2014.56.4229

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Male
Prostatic Neoplasms / radiotherapy*
Prostatic Neoplasms / surgery*